Polaryx Therapeutics, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
49.8M
on 2026-06-30, from 47.3M on 2025-12-31 10-Q ↗
a raise that quarter, at its price
Newest
None
No S-3 or F-3 shelf on file in the last 30 months.
None
No at-the-market programme on file in the last 30 months.
Warrants
The 10-Q filed 2026-08-13 is not read yet.
Cash
Four quarters of operating cash flow to 2026-06-30 are not all on file.
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-05-27 | Private placement | 88,453 | not read | $10.0M | 8-K ↗ |